Abstract: Complex-valued neural networks (CVNNs) have become a hot research topic in neural network community for their powerful ability in dealing with complex-valued signal problems. However, as one ...

ADCs combine antibodies with drug payloads for targeted therapy, but complex manufacturing requires monitoring CQAs across multiple entities.

From the Department of Bizarre Anomalies: Microsoft has suppressed an unexplained anomaly on its network that was routing traffic destined to example.com—a domain reserved for testing purposes—to a ...

Adagene Inc. has announced a partnership with ConjugateBio Inc. to provide a proprietary antibody for the development of innovative bispecific antibody-drug conjugates (ADCs). Adagene's CEO ...

Mercifully, Complex in print form is back, this time with a new issue featuring interviews with Travis Scott, Jennie, and more. Below, we take a quick look at what else you can expect from the new ...

The novel “Goddess Complex,” by Sanjena Sathian, takes a sharp turn from an existential crisis into a more literal one. By R.O. Kwon R.O. Kwon is the author of the novels “Exhibit” and “The ...

NEW YORK--(BUSINESS WIRE)--OS Therapies, Inc. (NYSE-A: OSTX), a clinical-stage biotechnology company advancing immunotherapies and targeted drug conjugates for cancer treatment, announced the ...

Antibody-drug conjugates (ADCs) represent an emerging class of therapeutics across solid tumor oncology and are already positioned as a cornerstone therapy for patients with urothelial carcinoma (UC).

Article subjects are automatically applied from the ACS Subject Taxonomy and describe the scientific concepts and themes of the article. Antibodies and oligonucleotides, two powerful classes of ...

The original version of this story appeared in Quanta Magazine. A few centuries ago, the swirling polychromatic chaos of Jupiter’s atmosphere spawned the immense vortex that we call the Great Red Spot ...

Liam Gaughan is a film and TV writer at Collider. He has been writing film reviews and news coverage for ten years. Between relentlessly adding new titles to his watchlist and attending as many ...